Literature DB >> 16084890

Effects of aromatase inhibitors on proliferation and apoptosis in eutopic endometrial cell cultures from patients with endometriosis.

Gabriela F Meresman1, Mariela Bilotas, Verónica Abello, Ricardo Buquet, Marta Tesone, Carlos Sueldo.   

Abstract

OBJECTIVE: To study the effect of letrozole (Let) and anastrozole (Anas) on apoptosis and cell proliferation in epithelial endometrial cells (EEC) from patients with endometriosis (EDT).
DESIGN: Prospective study.
SETTING: Research institute and clinical fertility center. PATIENT(S): Eighteen women with untreated EDT. INTERVENTION(S): Biopsy specimens of eutopic endometrium were obtained from all subjects. Apoptosis and cell proliferation were examined in EEC after incubation with Let or Anas. MAIN OUTCOME MEASURE(S): Percentage of apoptotic cells (ApC) was evaluated by the acridine orange-ethidium bromide technique; cell proliferation was assessed by 3H-thymidine incorporation. RESULT(S): Treatment with Let 10 nM and Let 100 nM enhanced values of ApC in cultures from EDT patients. Epithelial endometrial cells treated with Anas 100 nM or Anas 500 nM showed a statistically significant induction on apoptosis levels. Cultures treated with Let 1 nM or Anas 50 nM did not show any significant differences in ApC levels compared with basal conditions. 3H-Thymidine uptake was down regulated by Let 10 nM and Let 100 nM. Similarly, Anas 100 nM and Anas 500 nM showed a significantly lower degree of cell proliferation in EEC. Lower concentrations of Let and Anas did not induce any significant change in cell proliferation rates. CONCLUSION(S): Our results show that Let and Anas produced a significant and positive effect on apoptosis and cell proliferation on EEC from EDT patients. These findings support the further investigation of aromatase inhibitors as a treatment option in EDT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16084890     DOI: 10.1016/j.fertnstert.2005.01.137

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Everolimus as an mTOR Inhibitor Suppresses Endometriotic Implants: an Experimental Rat Study.

Authors:  T Kacan; C Yildiz; S Baloglu Kacan; M Seker; H Ozer; A Cetin
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-01       Impact factor: 2.915

2.  Treatment of Endometriosis and Chronic Pelvic Pain with Letrozole and Norethindrone Acetate.

Authors:  S Chawla
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 3.  Aromatase inhibitors in post-menopausal endometriosis.

Authors:  Nikolaos P Polyzos; Human M Fatemi; Apostolos Zavos; Grigoris Grimbizis; Dimitra Kyrou; Juan-Garcia Velasco; Paul Devroey; Basil Tarlatzis; Evangelos G Papanikolaou
Journal:  Reprod Biol Endocrinol       Date:  2011-06-21       Impact factor: 5.211

Review 4.  Dysmenorrhea in adolescents: diagnosis and treatment.

Authors:  Linda French
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

5.  The involvement of osteopontin and matrix metalloproteinase- 9 in the migration of endometrial epithelial cells in patients with endometriosis.

Authors:  Mei Yang; Chunfan Jiang; Hua Chen; Yan Nian; Zhimiao Bai; Chunfang Ha
Journal:  Reprod Biol Endocrinol       Date:  2015-08-20       Impact factor: 5.211

Review 6.  Medical treatments for endometriosis-associated pelvic pain.

Authors:  Gabriella Zito; Stefania Luppi; Elena Giolo; Monica Martinelli; Irene Venturin; Giovanni Di Lorenzo; Giuseppe Ricci
Journal:  Biomed Res Int       Date:  2014-08-07       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.